In this week’s video, Dr. Brian GM Durie explains how to determine if monoclonal protein spikes in the blood are actually spikes due to daratumumab therapy.

BOTTOM LINE:

When assessing response, ensure that a monoclonal protein spike is not a dara spike with the proper tests.

Have a question? Submit it to AskDrDurie@myeloma.org

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org

Previous Post
Daratumumab in the News Again: Showing Benefit in Frontline and at Relapse
Next Post
Closing or Halting of Myeloma Immune Therapy Trials: A Major Setback for Patients and Drug Companies

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.